BIODESIX INC (BDSX) Form S-3 — May 21, 2026
Biodesix, Inc. filed a Form S-3 registration statement to register the resale of up to 375,000 shares of common stock issuable upon the exercise of warrants held by Perceptive Credit Holdings IV, LP. These warrants were granted to Perceptive as consideration for amendments to a credit agreement, with the most recent amendment dated February 25, 2026. Biodesix will not receive any proceeds from the sale of these shares by the selling stockholder.
Key figures
- Gross Proceeds
- 5426250
- Offering Price
- 14.47
- Shares Offered
- 375000
- Shares Outstanding
- 10355809
- Reverse split ratio
- 1:20
- Warrant exercise price
- Not stated in filing (implied by warrant terms not included)
- Selling stockholder ownership percent
- 4.67
Price after filing
1 day: 0.0%7 days: +5.3%30 days: +10.7%
Close on the filing date to close N calendar days later (from $15.18). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.